weezion

About weezion

The startup develops diagnostic solutions for the rapid and cost-effective in vitro detection of bacteremia and fungemia, focusing on the identification of microorganisms and their antibiotic resistance profiles. Their technology enhances the accuracy and speed of microbial infection diagnosis in blood samples, addressing critical delays in treatment decisions.

The startup develops diagnostic solutions for the rapid and cost-effective in vitro detection of bacteremia and fungemia, focusing on the identification of microorganisms and their antibiotic resistance profiles. Their technology enhances the accuracy and speed of microbial infection diagnosis in blood samples, addressing critical delays in treatment decisions.

What does weezion do?

The startup develops diagnostic solutions for the rapid and cost-effective in vitro detection of bacteremia and fungemia, focusing on the identification of microorganisms and their antibiotic resistance profiles. Their technology enhances the accuracy and speed of microbial infection diagnosis in blood samples, addressing critical delays in treatment decisions.

Where is weezion located?

weezion is based in Vergisson, France.

How much funding has weezion raised?

weezion has raised $2.1M.

Location
Vergisson, France
Funding
$2.1M
Employees
9 employees

weezion

9
Relative Traction Score based on online presence metrics compared to companies in the same age group.

Executive Summary

The startup develops diagnostic solutions for the rapid and cost-effective in vitro detection of bacteremia and fungemia, focusing on the identification of microorganisms and their antibiotic resistance profiles. Their technology enhances the accuracy and speed of microbial infection diagnosis in blood samples, addressing critical delays in treatment decisions.

weezion.com200+
Vergisson, France

Funding

No specific funding rounds found.

Total Funding

$2.1M

Team (5+)

No team information available.

Company Description

The startup develops diagnostic solutions for the rapid and cost-effective in vitro detection of bacteremia and fungemia, focusing on the identification of microorganisms and their antibiotic resistance profiles. Their technology enhances the accuracy and speed of microbial infection diagnosis in blood samples, addressing critical delays in treatment decisions.

Sources:

1
This profile is AI-generated from web data and may contain inaccuracies. Want to correct or remove an entry? Owners can claim edits via their company email domain, and signed-in users can submit sourced suggestions.